PROFUSA, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
PROFUSA, INC. (PFSA) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $188.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-19
- PROFUSA, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $188.00K, a 129.27% increase year-over-year.
- PROFUSA, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $187.00K, a 3640.00% increase year-over-year.
- PROFUSA, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $189.00K, a 3680.00% increase year-over-year.
- PROFUSA, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $82.00K, a 1266.67% increase year-over-year.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $188.00K 10-Q · filed 2026-08-19 | $375.00K derived: sum of 2 quarters · filed 2026-08-19 | ||
| 2026-03-31 | $187.00K 10-Q · filed 2026-08-19 | |||
| 2025-12-31 | $463.00K S-1/A · filed 2026-05-01 | |||
| 2025-09-30 | $189.00K 10-Q · filed 2025-11-19 | $271.00K derived: sum of 2 quarters · filed 2026-08-19 | $276.00K derived: sum of 3 quarters · filed 2026-08-19 | |
| 2025-06-30 | $82.00K 10-Q · filed 2026-08-19 | $87.00K derived: sum of 2 quarters · filed 2026-08-19 | ||
| 2025-03-31 | $5.00K 10-Q · filed 2026-08-19 | |||
| 2024-12-31 | $21.00K S-1/A · filed 2026-05-01 | |||
| 2024-09-30 | $5.00K 10-Q · filed 2025-11-19 | $11.00K derived: sum of 2 quarters · filed 2025-11-19 | $16.00K derived: sum of 3 quarters · filed 2025-11-19 | |
| 2024-06-30 | $6.00K 10-Q · filed 2025-11-19 | $11.00K derived: sum of 2 quarters · filed 2025-11-19 | ||
| 2024-03-31 | $5.00K 10-Q · filed 2025-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |